Efficacy of a Plasmodium vivax Malaria Vaccine Using ChAd63 and Modified Vaccinia Ankara Expressing Thrombospondin-Related Anonymous Protein as Assessed with Transgenic Plasmodium berghei Parasites

Plasmodium vivax is the world's most widely distributed malaria parasite and a potential cause of morbidity and mortality for approximately 2.85 billion people living mainly in Southeast Asia and Latin America. Despite this dramatic burden, very few vaccines have been assessed in humans. The cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauza, Karolis, Malinauskas, Tomas, Pfander, Claudia, Anar, Burcu, Jones, E. Yvonne, Billker, Oliver, Hill, Adrian V. S., Reyes-Sandoval, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2014
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957994/
https://www.ncbi.nlm.nih.gov/pubmed/24379295
http://dx.doi.org/10.1128/IAI.01187-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957994/
https://www.ncbi.nlm.nih.gov/pubmed/24379295
http://dx.doi.org/10.1128/IAI.01187-13

Ejemplares similares